ANZUP's A little below the belt magazine | July 2021

Page 34

In the media:

This is the only cancer where survival rates are decreasing in Australia It’s time to talk about it. Credit: Cassandra Green | Body and Soul | April 29, 2021

Melissa Le Mesurier thought she just had a bad UTI. She couldn’t have been more shocked to find out it was cancer. Four years ago, Melissa Le Mesurier went to the doctor for what she thought was a persistent UTI. Little did she know she was about to be diagnosed with bladder cancer, the only cancer where survival rates are decreasing in Australia. Her symptoms were minimal. She was having trouble passing urine but feeling the urge to go. It gradually got worse and after not being able to pass urine for 12 hours on holiday, she knew it was time to see a specialist. Her urologist, Professor Shomik Sengupta performed a cystoscopy (visualisation of the bladder via a camera) and a tumour was found. Just a few weeks later she was back in to get it removed (thankfully it hadn’t invaded the muscle wall or metastasised elsewhere in the body). “The good news was that with early detection and treatment, this type of cancer has a five year survival rate of 95%. It’s not so good news for those diagnosed with a bladder cancer that has spread into the bladder wall (69% survival rate) or beyond the bladder cancer wall (33%). So, all in all, I considered myself lucky,” she says. However, awareness and diagnosis isn’t always that easy. “If your doctor suspects you have bladder cancer, they will examine you and arrange tests,” says her urologist Professor Sengupta.

“The tests you have will depend on your specific situation and may include: general tests (usually blood and urine) to check your overall health and body function, tests to find cancer (usually scans and internal inspection of the bladder using a fibreoptic instrument known as a cystoscope), and further tests (usually additional scans) to see if the cancer has spread (metastasised). Some tests may be repeated later to see how the treatment is working.” As the diagnosis process is somewhat invasive, there is no national testing scheme, the same way they detect bowel and breast cancer. This means that patients must self-report symptoms, which is a much less reliable form of detection. Without more awareness for this type of cancer and the symptoms, diagnosis can be delayed, and survival chances drop significantly. So what are the symptoms? “The most common symptom of bladder cancer is blood in the urine (haematuria). This usually occurs suddenly and is generally not painful. Other less common symptoms include: a burning sensation when passing urine, pain when urinating, needing to pass urine often, problems emptying the bladder, back pain or lower abdominal pain,” Professor Sengupta says. Melissa, however, didn’t have the full gamut of symptoms.

Article source and copyright attributed here: https://www.bodyandsoul.com.au/health/this-is-the-only-cancer-where-survival-rates-are-decreasing-in-australia/news-story/7d78d9d08c1d7c29a28 ec0e7c139a511?utm_campaign=EditorialSB&utm_source=body%2Bsoul&utm_medium=Facebook&utm_content=SocialBakers

34 A LITTLE BELOW THE BELT


Turn static files into dynamic content formats.

Create a flipbook

Articles inside

2021 Move #YourWay ambassadors

4min
pages 66-68

See your suburb #YourWay / The mini challenges

2min
page 64

Strengthening immune therapy in kidney cancer the goal of the KEYPAD clinical trial

2min
page 50

Spotlight on penile cancer

4min
pages 53-54

How does your donation make a difference?

0
page 60

Belt Research Fund

6min
pages 62-63

Community Fundraising

3min
pages 58-59

ANZUP trials – kidney

3min
pages 51-52

Hillcrest Foundation supports ANZUP’s Kidney Cancer Project / New ANZUP website

1min
page 49

I firmly believe a clinical trial saved my life

9min
pages 46-48

Spotlight on kidney cancer

5min
pages 44-45

ANZUP trials – testicular

4min
pages 42-43

Worldwide prostate cancer trial now open internationally

1min
page 25

ANZUP trials – bladder

2min
pages 37-38

ANZUP co-badged study ProPSMA wins ACTA Trial of the Year for 2021

1min
page 27

ENZAMET – NEJM, QoL Translational update

3min
page 26

This is the only cancer where survival rates are decreasing in Australia. It’s time to talk about it.

5min
pages 34-35

International Germ Cell Cancer Collaborative Group update: positive news for seminoma germ cell cancer patients

2min
page 41

A new class of effective therapy for men with metastatic castration-resistant prostate cancer

2min
pages 23-24

CEO Update

7min
pages 7-8

Spotlight on prostate cancer

5min
pages 21-22

Friends of ANZUP

0
page 12

New ANZUP Trials coming soon

5min
pages 17-18

Consumer Advisory Panel (CAP) Update

2min
page 9

Scientists sit-up for world-first clinical trial into prostate cancer

6min
pages 19-20

Prostate Cancer Specialist Nurses improving quality of care for cancer patients

6min
pages 13-15

Message from the Chair, Professor Ian Davis

8min
pages 5-6
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.